Search
Filter Results
Displaying 561–570 of 723 for “Visions 2020”
-
Lighting The Way. The book celebrating 50 years of driving the research for blinding diseases.
-
Mar 15, 2022
Aldeyra Launches Phase 2 Clinical Trial of Methotrexate Intravitreal Injections for RP
Lab studies showed the drug can effectively address the misfolded rhodopsin protein
-
Mar 7, 2022
Neurogene to Launch Gene Therapy Clinical Trial for Children with Batten Disease
The treatment will be delivered to the vitreous of the eye and ventricles of the brain
-
Feb 1, 2022
Genentech-Roche Receives FDA Approval for Vabysmo for Treatment of Wet AMD and DME
This new treatment can reduce the frequency of injections into the eye
-
Jan 5, 2022
Dr. Thomas Chalberg has been recognized by the Foundation Fighting Blindness for his pioneering contributions to research and development.
-
Oct 18, 2021
Atsena Therapeutics Developing X-Linked Retinoschisis Gene Therapy
The emerging gene therapy is being designed to more safely reach the fovea
-
Oct 13, 2021
Foundation Fighting Blindness Appoints Richele Donat, SPHR, as Chief Human Resources Officer
Ms. Donat brings over twenty years of successful human resource leadership experience to the Foundation executive team
-
Oct 7, 2021
Covid Revealed What Science Can Do When Funding is Found
‘In some ways, the pandemic ought to make us all feel more upbeat about the long-term future of medical research.’
-
Oct 4, 2021
RD Fund Appoints Tony Adamis, MD to Board of Directors
The RD Fund announces the appointment of Anthony (Tony) Adamis, MD, to its board of directors.
-
Sep 28, 2021
RD Fund Launches Opus Genetics to Advance Gene Therapies for Inherited Retinal Diseases
First two programs are for Leber congenital amaurosis: LCA5-lebercillin and LCA13-RDH12